LifeVantage (LFVN) Stock Chart & Stock Price History → These AI trades triggered this morning (545% return) (From Prosper Trading Academy) (Ad) Free LFVN Stock Alerts $6.18 -0.06 (-0.96%) (As of 04/26/2024 08:52 PM ET) Add Compare Share Share ChartStock AnalysisChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability LifeVantage Stock Price Performance5 Day Performance-3.43%1 Month Performance+2.23%3 Month Performance+7.01%6 Month Performance-20.71%Year-To-Date Performance+3.08%1 Year Performance+87.42% Receive LFVN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for LifeVantage and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Colonial MetalsConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareThe latest flare-up between Israel and Palestinian militants has sent gold prices surging. Why? Because savvy investors know the endgame of the elites at play… Geopolitical crises breed uncertainty — and gold thrives on uncertainty. See why the elites are pouring billions into gold. LFVN Stock Chart for Monday, April, 29, 2024 LFVN Chart by TradingView LifeVantage Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/26/2024$6.24$6.19-0.88%$6.41$6.0018,276 shs$79.60 million04/25/2024$6.17$6.24+1.13%$6.26$6.135,015 shs$80.31 million04/24/2024$6.41$6.17-3.67%$6.61$6.1018,252 shs$79.40 million04/23/2024$6.05$6.41+5.87%$6.47$6.0021,781 shs$82.43 million04/22/2024$6.70$6.05-9.70%$6.72$6.0342,786 shs$77.86 million04/19/2024$6.66$6.70+0.60%$6.99$6.6488,388 shs$86.22 million Get the Latest News and Ratings for LFVN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for LifeVantage and its competitors with MarketBeat's FREE daily newsletter. 04/18/2024$6.60$6.66+0.91%$6.70$6.5723,350 shs$85.71 million04/17/2024$6.26$6.60+5.43%$6.61$6.1355,867 shs$84.94 million04/16/2024$5.75$6.26+8.87%$6.26$5.6650,299 shs$80.57 million04/15/2024$6.19$5.75-7.11%$6.19$5.7524,932 shs$74.00 million04/12/2024$6.08$6.19+1.81%$6.27$6.0812,152 shs$79.67 million04/11/2024$6.15$6.08-1.14%$6.31$6.0135,187 shs$78.25 million04/10/2024$6.12$6.15+0.49%$6.19$6.107,619 shs$79.15 million04/09/2024$6.14$6.12-0.33%$6.31$6.129,074 shs$78.76 million04/08/2024$6.20$6.14-0.97%$6.36$6.1422,794 shs$79.02 million04/05/2024$6.20$6.20+0.08%$6.25$6.0816,069 shs$79.78 million04/04/2024$6.14$6.20+0.90%$6.37$6.1717,980 shs$79.73 million04/03/2024$6.47$6.14-5.10%$6.46$6.0629,486 shs$79.02 million04/02/2024$6.39$6.47+1.25%$6.58$6.3322,863 shs$83.27 million04/01/2024$6.05$6.39+5.62%$6.45$5.8534,601 shs$82.24 million03/29/2024$6.05$6.05$6.50$5.8333,633 shs$77.86 million03/28/2024$6.21$6.05-2.58%$6.50$5.9133,633 shs$77.86 million03/27/2024$6.18$6.21+0.49%$6.27$6.1413,934 shs$79.92 million03/26/2024$6.27$6.18-1.44%$6.25$6.0637,939 shs$79.54 million03/25/2024$6.90$6.27-9.13%$6.82$6.2747,333 shs$80.68 million03/22/2024$6.93$6.90-0.43%$6.97$6.7013,131 shs$88.80 million03/21/2024$6.96$6.93-0.43%$7.00$6.9118,418 shs$89.19 million03/20/2024$6.95$6.96+0.14%$7.01$6.9111,194 shs$89.56 million03/19/2024$6.92$6.95+0.43%$7.03$6.9228,535 shs$89.45 million03/18/2024$7.00$6.92-1.14%$7.05$6.8545,451 shs$89.06 million03/15/2024$6.89$7.00+1.60%$7.00$6.8527,250 shs$90.08 million03/14/2024$6.84$6.89+0.73%$6.99$6.8626,746 shs$88.67 million03/13/2024$6.88$6.84-0.58%$6.95$6.8025,890 shs$88.03 million03/12/2024$6.93$6.88-0.72%$7.04$6.8739,142 shs$88.55 million03/11/2024$6.95$6.93-0.22%$7.02$6.8040,374 shs$89.19 million03/08/2024$6.90$6.95+0.65%$7.03$6.9031,159 shs$89.38 million03/07/2024$6.96$6.90-0.86%$7.02$6.9031,900 shs$88.80 million03/06/2024$7.00$6.96-0.57%$7.05$6.9639,388 shs$89.56 million03/05/2024$6.93$7.00+1.01%$7.08$6.9141,691 shs$90.09 million03/04/2024$7.00$6.93-1.00%$7.05$6.9057,408 shs$89.19 millionConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share (Ad)The latest flare-up between Israel and Palestinian militants has sent gold prices surging. Why? Because savvy investors know the endgame of the elites at play… Geopolitical crises breed uncertainty — and gold thrives on uncertainty. See why the elites are pouring billions into gold.03/01/2024$6.82$7.00+2.64%$7.05$6.8547,679 shs$90.08 million02/29/2024$7.01$6.82-2.71%$7.03$6.8036,405 shs$87.77 million02/28/2024$6.87$7.01+2.04%$7.01$6.8335,598 shs$90.22 million02/27/2024$6.98$6.87-1.58%$7.00$6.8338,278 shs$88.42 million02/26/2024$6.73$6.98+3.71%$7.01$6.6348,626 shs$89.83 million02/23/2024$6.81$6.73-1.17%$7.01$6.6037,800 shs$86.62 million02/22/2024$6.98$6.81-2.44%$7.09$6.8136,053 shs$87.65 million02/21/2024$6.92$6.98+0.87%$7.06$6.8639,967 shs$89.82 million02/20/2024$6.85$6.92+1.02%$7.12$6.8040,207 shs$89.06 million02/19/2024$6.85$6.85$7.23$6.46113,200 shs$88.16 million02/16/2024$6.49$6.85+5.55%$7.23$6.46113,270 shs$88.16 million02/15/2024$6.43$6.49+0.93%$6.55$6.1758,854 shs$83.53 million02/14/2024$6.26$6.43+2.72%$6.72$6.2571,366 shs$82.75 million02/13/2024$6.48$6.26-3.40%$6.38$6.0831,325 shs$80.57 million02/12/2024$6.61$6.48-1.97%$7.14$6.3774,593 shs$83.40 million02/09/2024$6.20$6.61+6.61%$6.65$6.0968,692 shs$85.07 million02/08/2024$6.10$6.20+1.64%$6.23$6.0542,550 shs$79.79 million02/07/2024$6.05$6.10+0.83%$6.25$6.0024,502 shs$78.51 million02/06/2024$5.78$6.05+4.67%$6.05$5.7855,240 shs$77.85 million02/05/2024$5.59$5.78+3.40%$5.99$5.6573,020 shs$74.39 million02/02/2024$5.47$5.59+2.19%$5.74$5.3534,304 shs$71.94 million02/01/2024$5.31$5.47+3.01%$5.48$5.2262,592 shs$69.55 million01/31/2024$5.83$5.31-8.92%$5.65$5.2752,651 shs$67.49 million01/30/2024$5.83$5.83$5.92$5.6913,496 shs$74.10 million01/29/2024$5.78$5.83+0.87%$6.04$5.8020,706 shs$74.10 million Related Companies: Chimerix Stock Chart Leap Therapeutics Stock Chart Q32 Bio Stock Chart Affimed Stock Chart Aileron Therapeutics Stock Chart Eton Pharmaceuticals Stock Chart InflaRx Stock Chart Oncolytics Biotech Stock Chart Reviva Pharmaceuticals Stock Chart Marinus Pharmaceuticals Stock Chart Receive LFVN Stock News and Ratings via EmailSign-up to receive the latest news and ratings for LifeVantage and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:LFVN) was last updated on 4/29/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsHis win rate puts Warren Buffett to shame… Investing DailyDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyBiden out June 13; Kamala won’t replace him?Paradigm PressMan Who Predicted 2008: “This Will be Worse.”AltimetryThe World's First "$20 Trillion Drug?"Behind the Markets Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding LifeVantage Co. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.